FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (48)Update on LATIFY Phase III trial of ceralasertib
Preheader (119)Update on LATIFY Phase III trial of ceralasertib plus Imfinzi in previously treated advanced non-small cell lung cancer
Arial
Text Analysis
Body Words148
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px788 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeMorning
